Coming Soon: Artificial Limbs Controlled by Thoughts

The idea that paralyzed people might one day control their limbs just by thinking is no longer a Hollywood-style fantasy


Image: Kemp Remillard

In Brief

  • Brain waves can now control the functioning of computer cursors, robotic arms and, soon, an entire suit: an exoskeleton that will allow a paraplegic to walk and maybe even move gracefully.
  • Sending signals from the brain's outer rindlike cortex to initiate movement in the exoskeleton represents the state of the art for a number of bioelectrical technologies perfected in recent years.
  • The 2014 World Cup in Brazil will serve as a proving ground for a brain-controlled exoskeleton if, as expected, a handicapped teenager delivers the ceremonial opening kick.

In 2014 billions of viewers worldwide may remember the opening game of the World Cup in Brazil for more than just the goals scored by the Brazilian national team and the red cards given to its adversary. On that day my laboratory at Duke University, which specializes in developing technologies that allow electrical signals from the brain to control robotic limbs, plans to mark a milestone in overcoming paralysis.

If we succeed in meeting still formidable challenges, the first ceremonial kick of the World Cup game may be made by a paralyzed teenager, who, flanked by the two contending soccer teams, will saunter onto the pitch clad in a robotic body suit. This suit—or exoskeleton, as we call it—will envelop the teenager's legs. His or her first steps onto the field will be controlled by motor signals originating in the kicker's brain and transmitted wirelessly to a computer unit the size of a laptop in a backpack carried by our patient. This computer will be responsible for translating electrical brain signals into digital motor commands so that the exoskeleton can first stabilize the kicker's body weight and then induce the robotic legs to begin the back-and-forth coordinated movements of a walk over the manicured grass. Then, on approaching the ball, the kicker will visualize placing a foot in contact with it. Three hundred milliseconds later brain signals will instruct the exoskeleton's robotic foot to hook under the leather sphere, Brazilian style, and boot it aloft.

This scientific demonstration of a radically new technology, undertaken with collaborators in Europe and Brazil, will convey to a global audience of billions that brain control of machines has moved from lab demos and futuristic speculation to a new era in which tools capable of bringing mobility to patients incapacitated by injury or disease may become a reality. We are on our way, perhaps by the next decade, to technology that links the brain with mechanical, electronic or virtual machines. This development will restore mobility, not only to accident and war victims but also to patients with ALS (also known as Lou Gehrig's disease), Parkinson's and other disorders that disrupt motor behaviors that impede arm reaching, hand grasping, locomotion and speech production. Neuroprosthetic devices—or brain-machine interfaces—will also allow scientists to do much more than help the disabled. They will make it possible to explore the world in revolutionary ways by providing healthy human beings with the ability to augment their sensory and motor skills.

In this futuristic scenario, voluntary electrical brain waves, the biological alphabet that underlies human thinking, will maneuver large and small robots remotely, control airships from afar, and perhaps even allow the sharing of thoughts and sensations of one individual with another over what will become a collective brain-based network.

Thought Machines

The lightweight body suit intended for the kicker, who has not yet been selected, is still under development. A prototype, though, is now under construction at the lab of my great friend and collaborator Gordon Cheng of the Technical University of Munich—one of the founding members of the Walk Again Project, a nonprofit, international collaboration among the Duke University Center for Neuroengineering, the Technical University of Munich, the Swiss Federal Institute of Technology in Lausanne, and the Edmond and Lily Safra International Institute of Neuroscience of Natal in Brazil. A few new members, including major research institutes and universities all over the world, will join this international team in the next few months.

The project builds on nearly two decades of pioneering work on brain-machine interfaces at Duke—research that itself grew out of studies dating back to the 1960s, when scientists first attempted to tap into animal brains to see if a neural signal could be fed into a computer and thereby prompt a command to initiate motion in a mechanical device. Back in 1990 and throughout the first decade of this century, my Duke colleagues and I pioneered a method through which the brains of both rats and monkeys could be implanted with hundreds of hair-thin and pliable sensors, known as microwires. Over the past two decades we have shown that, once implanted, the flexible electrical prongs can detect minute electrical signals, or action potentials, generated by hundreds of individual neurons distributed throughout the animals' frontal and parietal cortices—the regions that define a vast brain circuit responsible for the generation of voluntary movements.

Biomarker Predicts Recovery from a Type of Depression

A new study signifies the beginning of the end of psychiatrists' guess-work in figuring out which antidepressants work best for individual patients


man and rain Image: Jiri Hodan

By Amy Maxmen of Nature magazine

People who live with clinical depression must also suffer the ‘trial and error’ approach that psychiatrists take when prescribing antidepressants. Now, a study published this week signifies the beginning of the end of guesswork. In it, a blood test predicts who will respond well to a novel treatment for depression, and who might even fare worse.“We haven’t had a test like this in psychiatry before,” says Andy Miller, a professor of psychiatry at Emory University and an author on the study in Archives of General Psychiatry. “There is no brain scan, no physiological measure that tells you whether a patient will respond to one drug more than another.”

The test identifies an inflammatory protein in blood, C-reactive protein or CRP, that indicates internal inflammation. Whereas 62% of depressed participants with high CRP levels responded well to the new treatment, only 33% of participants with low CRP levels did.

The correlation was not entirely unexpected, because the drug suppresses inflammation, and Miller thinks that inflammation underlies depression in some people. To test whether a potent anti-inflammatory could soothe the malady, his team recruited 60 people who had lived with major depression for more than a decade and had received no relief from antidepressants.

Half of the participants received monthly treatments of the rheumatoid arthritis drug, Janssen’s Infliximab, and half received a placebo. Overall, Infliximab did not seem to work. However, when Miller’s team analyzed how the subset of participants with high CRP faired, it turns out they responded well to the drug, with a relief from sadness, suicidal thoughts, anxiety and other symptoms.

Since the late 1980s, researchers have sporadically hypothesized that inflammation can lead to depression. The theory is that depressed behavior might be beneficial in the short term because it reserves an injured animal’s energy for healing rather than romping around in the sunlight. Although the hypothesis has never received widespread support, researchers have found that some depressed patients indeed bear elevated levels of inflammatory proteins.

On the basis of the results from this relatively small study, a biologic drug such as Infliximab might be a better option in the anti-inflammatory realm than Cox-2 inhibitors such as aspirin, which come with unwanted side effects, says Miller. Although he knows of no Infliximab-like drug in development for depression, he says that companies might be encouraged by his team’s results. What’s more, with a biomarker to predict a response, companies will have a better chance of success.

Robert Dantzer, a neuroimmunologist at MD Anderson Cancer Center in Houston, Texas, notes that some of the participants in the low-CRP group fared worse on Infliximab than on placebo. Thus, the CRP test could be as important a tool for excluding depressed patients from taking anti-inflammatory therapies as for predicting responders.

This article is reproduced with permission from the magazine Nature. The article was first published on September 5, 2012.

Apple's iPhone 5 bigger, faster but lacks "wow"{wow was the last words of steve job}


Reuters
San Francisco, September 13, 2012
First Published: 07:42 IST(13/9/2012)
Last Updated: 08:13 IST(13/9/2012)
The new iPhone 5 is displayed during an Apple special event at the Yerba Buena Center for the Arts in San Francisco, California. AFP Photo
Apple Inc's new iPhone 5 goes on sale on Friday with a bigger screen and 4G wireless technology, as the company seeks to safeguard its edge over rivals like Samsung Electronics Co Ltd and Google Inc.

The iPhone 5 fulfilled many of the expectations laid out by gadget geeks and technology analysts ahead of its Wednesday unveiling but offered few surprises to give Apple shares -- already near record highs -- another major kick.

"There is not a wow factor because everything you saw today is evolutionary. I do think they did enough to satisfy," said Michael Yoshikami, chief executive of wealth management company Destination Wealth Management.

Other industry analysts speculated about what else was in Apple's product pipeline ahead of the crucial year-end holiday season, especially since the company stayed mum about an oft-rumored TV device or a smaller iPad.

The consumer electronics giant that in 2010 popularized tablet computing with the iPad has given no hints on whether it plans a smaller version to match cheaper tablets from the likes of Google or Amazon.com Inc.


Phil Schiller introduces Apple's new iPhone 5 in San Francisco. Reuters Photo
"We would really like to see the iPad Mini in the product offering for the all-important holiday quarter. They still have time," said Channing Smith, co-manager of the Capital Advisors Growth Fund.

"As soon as we see that, we will have more conviction about the stock heading into the final quarter."

Apple shares ended the day up 1.4% at $669.79. How iPhone became King of smartphones

The latest iPhone comes as Apple faces competition beyond current key competitors Samsung and Google.

Late entrant Microsoft Corp is now trying to push its Windows Phone 8 operating system as an alternative to Apple and Android, the most-used smartphone operating system in the world.

Analysts have forecast sales of 10 million to 12 million of the new iPhones in this month alone.

Apple chief executive Tim Cook kicked off the event in San Francisco's Yerba Buena Center but it was marketing chief Phil Schiller who introduced the iPhone 5 and took the audience through the new phone's features.

The iPhone 5 sports a 4-inch "retina" display, can surf a high-speed 4G LTE wireless network, and is 20% lighter than the previous iPhone 4S.

Ceding a lead

It ships Sept. 21 in the United States, Australia, Canada, France, Germany, Hong Kong, Japan, Singapore and Britain.

It will hit 100 countries by year's end in the fastest international rollout for an iPhone so far.


Phil Schiller introduces Apple's new iPhone 5 in San Francisco. Reuters Photo

The stakes are high with the iPhone, Apple's marque product, accounting for nearly half its revenue.

The California company has sold more than 243 million iPhones since 2007, when the device ushered in the current applications ecosystem model.

But Samsung now leads the smartphone market with a 32.6% share followed by Apple with 17%, according to market research firm IDC.

Both saw shipments rise compared to a year ago, with Samsung riding its flagship Galaxy S III phone. Apple iPhone 5: Top 5 rumours

Available for pre-order on Friday starting from $199 with a data plan, the iPhone 5 comes with Apple's newest "A6" processor, which executives said runs twice as fast as the previous generation.

It will pack three microphones -- enhancing built-in voice assistant Siri -- and an 8 megapixel camera that can take panoramic views.

It will hitch a ride on the three largest US carriers: Verizon Wireless, AT&T Inc, and Sprint. One popular enhancement was improved battery endurance -- the iPhone 5 can support eight hours of 4G Web browsing, the company said.

While Apple played catch-up on many of the new phone's features -- Samsung and Google's Motorola already have larger and 4G-ready phones -- analysts say the device's attraction is the way its software and hardware work in tandem.

"Where they are pushing the envelope, and where they remain the one to beat, is on the experience those features bring to the consumer," said Carolina Milanesi, Gartner Research analyst.

"While other vendors continue to focus just on the hardware -- delivering the speeds and feeds and bigger batteries -- Apple focuses on pulling the operating system, the hardware and what you can consume on the hardware."

Foo fighters rock

Cook began the event by giving updated metrics on the company's products and then quickly gave up the stage for Schiller to introduce the iPhone 5.


Apple's iPhone 5 and Samsung Galaxy SIII. Reuters and AFP Photos

The team then moved on to a new lineup of iPods, a redesigned iTunes store and ended with a surprise performance by rock band Foo Fighters.

Apple executives in the front row could be seen rocking their heads to "Times Like These" and other hits.

For the iPhone 5, Apple has done away with the connectors used on previous devices and replaced them with a smaller and more efficient "Lightning" connector.

With the iPhone, it is shipping new "EarPods" audiophones, designed after digitally scanning hundreds of ears.

Shares in Skullcandy, which specializes in stylized earphones, fell 4.5% on Wednesday.


Apple's iPhone 5 showing 3D maps. Reuters Photos

Beyond hardware, Apple telegraphed many of the software changes to expect in iPhone 5 when it debuted iOS 6, its latest mobile operating system, in June.

Upgrades to the software include voice navigation for driving, a feature already available on many Android smartphones, as well as "Passbook" for storing electronic boarding passes, sports tickets and gift cards.

Siri has been improved. In an onstage demonstration, Siri was able to answer questions about the result of a recent pro football game and recite a list of movies playing around town, along with ratings.

Earlier, Cook told the audience that its apps store now has more than 700,000 on tap -- the industry's largest library.

"When you look at each of these, they are incredible industry-leading innovations by themselves. But what sets them apart, and what places Apple way out in front of the competition, is how they work so well together," Cook said toward the end of the two-hour presentation.

====================================================================

Steve Jobs's last words: 'Oh wow. Oh wow. Oh wow'

Mona Simpson, sister of the late Apple co-founder, reveals details of the final moments Jobs spent with his family

Steve jobs
Steve Jobs's last words, revealed by his sister Mona Simpson, were 'Oh wow'. Photograph: Jeff Chiu/AP

The last words of the late, much-lauded and much-quoted Steve Jobs have been revealed almost a month after the Apple co-founder died at the age of 56.

Jobs, who once memorably described death as "very likely the single best invention of life", departed this world with a lingering look at his family and the simple, if mysterious, observation: "Oh wow. Oh wow. Oh wow."

Details of his final moments came from his sister Mona Simpson, who has allowed the New York Times to publish the eulogy she delivered at his memorial service on 16 October. In it, she explains how she rushed to Jobs's bedside after he asked her to come to see him as soon as possible.

"His tone was affectionate, dear, loving, but like someone whose luggage was already strapped onto the vehicle, who was already on the beginning of his journey, even as he was sorry, truly deeply sorry, to be leaving us," she writes.

When she arrived, she found Jobs surrounded by his family – "he looked into his children's eyes as if he couldn't unlock his gaze," – and managing to hang on to consciousness she said.

However, he began to deteriorate. "His breathing changed. It became severe, deliberate, purposeful. I could feel him counting his steps again, pushing farther than before. This is what I learned: he was working at this, too. Death didn't happen to Steve, he achieved it."

After making it through one final night, wrote Simpson, her brother began to slip away. "His breath indicated an arduous journey, some steep path, altitude. He seemed to be climbing.

"But with that will, that work ethic, that strength, there was also sweet Steve's capacity for wonderment, the artist's belief in the ideal, the still more beautiful later.

"Steve's final words, hours earlier, were monosyllables, repeated three times.

"Before embarking, he'd looked at his sister Patty, then for a long time at his children, then at his life's partner, Laurene, and then over their shoulders past them.

"Steve's final words were: 'Oh wow. Oh wow. Oh wow.'"